RACHAEL SOOD: Open Payments
NPI 1902181209 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$52,315 in 123 payments from 11 companies in 2025. Trend: 2023 $3,984 · 2024 $14,616 · 2025 $52,315
Speaker / faculty: $16,100Travel & lodging: $12,855Consulting: $11,315Speaker / faculty: $9,825Food & beverage: $2,221
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 61 | $26,224 |
| Dexcom, Inc. | 32 | $13,813 |
| SANOFI-AVENTIS U.S. LLC | 7 | $5,761 |
| Sequel Med Tech, LLC | 2 | $3,217 |
| Novo Nordisk Inc | 9 | $1,725 |
| Medtronic, Inc. | 6 | $1,243 |
| BETA BIONICS, INC. | 2 | $122 |
| CeQur Corporation | 1 | $101 |
| Ascensia Diabetes Care Us Inc. | 1 | $46 |
| Abbott Laboratories | 1 | $45 |
Products named: MOUNJARO, DEXCOM G7 GSS (161), TZIELD, TWIIST, Rybelsus, MINIMED 780G, iLet Bionic Pancreas, CeQur Simplicity.
Industry payments across LA — which companies pay providers there.
